The County Council’s Committee on Knowledge Management (KUST) made the decision in early September that the STAN-method, which is the method developed by Neoventa, will not be used during childbirth in the Stockholm County. The recommendation is to use the method only in a controlled clinical trial to make further scientific evaluation possible.
KUST based its decision on a recently published report from the Method Council for the Stockholm County Council – Region Gotland, “Fetal monitoring with computerized ST analysis …

Kommittén för Kunskapsstyrning (KUST) inom Stockholms Läns Landsting beslutade i början av september att STAN-metoden, det vill säga den metod som Neoventa har utvecklat, inte ska användas vid förlossningar inom Stockholms Läns Landsting. Om metoden ska användas får det endast ske inom ramen för en kontrollerad klinisk studie.
KUST bygger sitt ställningstagande på en rapport som Metodrådet vid Stockholms Läns Landsting – Region Gotland nyligen publicerade; “Fetal monitoring with computerized ST-analysis during labor – a systematic review” (Rapport 2011:3).
Metodrådet …

The Vice-Chancellor of Lund University has today announced its decision in the investigation of the Swedish STAN study. The Vice-Chancellor acquitted the research group behind the study of all allegations and notes that it is extremely unfortunate that the case has taken so long because it caused serious consequences for individuals.

Researchers at the Ångström Laboratory in Uppsala, Sweden have discovered a new method to manufacture nanomaterial sensors so that it becomes possible to for example measure different components of body liquids, i.e. blood or amniotic fluid.

Recently, a very large Swedish clinical study was published in the well recognized American Journal of Obstetrics and Gynecology.

The study is unique and summarizes all deliveries at one hospital over a seven year period. The results show that since the introduction of the STAN® monitor with ST Analysis, the number of babies born with asphyxia during birth has been reduced by more than 90%. The article states that this is a paradigm shift in the outcomes for deliveries.

The number of babies born with severe oxygen deficiency, asphyxia and brain damage has decreased sharply at the university clinics in the Nordic countries that use ST Analysis, a rather new Swedish method for fetal surveillance during labour. New statistics show a strong increase in safety at deliveries during the last few years. The new results were reported today at the 36th Nordic Congress of Obstetrics and Gynecology in Reykjavik, Iceland (NFOG).

The first STAN centre in the USA opened on Monday October 22nd in the labour and delivery unit at the Community Regional Medical Center and the University of California, Fresno Medical Education Program. The system, developed in Sweden by Neoventa Medical, is available in Europe since 2000 and in use in more than
350 labour delivery units.

Dutch company, Philips Medical Systems has signed a cooperation agreement with Swedish company, Neoventa Medical AB. The agreement means that the companies’ foetal monitoring systems will be compatible, and it will be possible to receive ST data in OB TraceVue from births monitored with STAN, which until present represent close to one million. “The agreement is a major success for both Neoventa and Philips,” says Neoventa’s CEO, Jan Stålemark, “It is further confirmation that the STAN method has been widely accepted.”

Investor Growth Capital and CapMan invest in Neoventa Medical AB, a Swedish medical technology company within the area of fetal monitoring. Following these investments, CapMan and Investor Growth Capital will each have an approximately 30% stake in Neoventa. The majority of the other shares will be retained by SEB Företagsinvest. The new shareholder structure will together secure a total capital injection of SEK 75 million that will finance the next phase of growth for Neoventa with a focus on the US market.

The U.S. Food and Drug Admistration (FDA) has approved the STAN® S31 Fetal heart monitor Pre-Market Approval (PMA) application. STAN from Neoventa Medical is the first fetal monitor proven to reduce the risk of brain injury during labor.